Header cover image

Materials Healthcare Sector

Results

2309

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2,309 companies

Bounce Mobile Systems

Market Cap: US$4.4m

Delex Healthcare Group, Inc. engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.

BNCM

US$0.0074

7D

0%

1Y

n/a

Regional Health Properties

Market Cap: US$4.4m

Operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living.

RHEP

US$2.60

7D

12.1%

1Y

-4.7%

Fuse Medical

Market Cap: US$4.4m

Manufactures and distributes medical devices in the United States.

FZMD

US$0.061

7D

0%

1Y

-25.7%

Filament Health

Market Cap: US$4.4m

Operates as a clinical-stage natural psychedelic drug development company in Canada.

FLHL.F

US$0.017

7D

-2.9%

1Y

-58.0%

Centogene

Market Cap: US$4.4m

Provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific.

CNTG.F

US$0.14

7D

0%

1Y

-61.8%

Raphael Pharmaceutical

Market Cap: US$4.4m

A pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids.

RAPH

US$0.22

7D

0%

1Y

n/a

Enzolytics

Market Cap: US$4.3m

Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

ENZC

US$0.0007

7D

-17.6%

1Y

-81.7%

Visionflex Group

Market Cap: AU$6.7m

Together its subsidiaries, engages in the provision of healthcare and corporate online search and appointment booking services in Australia.

VFX

AU$0.002

7D

0%

1Y

-66.7%

Adial Pharmaceuticals

Market Cap: US$4.3m

A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.

ADIL

US$0.66

7D

9.4%

1Y

-57.6%

Aptose Biosciences

Market Cap: CA$6.0m

A clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States.

APS

CA$2.36

7D

6.8%

1Y

-95.1%

Indiva

Market Cap: CA$5.9m

Engages in the production, processing, and sale of cannabis and cannabis related products in Canada.

NDVA.H

CA$0.03

7D

0%

1Y

-45.5%

Dermata Therapeutics

Market Cap: US$4.3m

A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.

DRMA

US$0.79

7D

-2.4%

1Y

-81.2%

Caduceus Software Systems

Market Cap: US$4.3m

Through its subsidiary, McLovin's Pet Food, Inc., operates as a pet food and pet care company.

CSOC

US$0.007

7D

20.7%

1Y

-58.7%

Encision

Market Cap: US$4.3m

A medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States.

ECIA

US$0.36

7D

-14.3%

1Y

-28.0%

Dogecoin Cash

Market Cap: US$4.3m

Through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States.

CBDS

US$0.031

7D

24.1%

1Y

52.6%

Quest PharmaTech

Market Cap: CA$5.9m

A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.

QPT

CA$0.035

7D

0%

1Y

75.0%

KMA Holding

Market Cap: US$4.2m

Through its subsidiaries, manufactures human and pet home medical test kits and emergency response mobile hospital units in the United States.

MCDA

US$0.0001

7D

0%

1Y

n/a

T2 Biosystems

Market Cap: US$4.2m

An in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally.

TTOO

US$0.16

7D

25.1%

1Y

-97.1%

Azitra

Market Cap: US$4.2m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

AZTR

US$0.27

7D

-8.4%

1Y

-95.1%

Nuwellis

Market Cap: US$4.2m

A medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.

NUWE

US$0.94

7D

-4.9%

1Y

-89.6%

Oragenics

Market Cap: US$4.2m

A development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States.

OGEN

US$0.20

7D

18.6%

1Y

-91.4%

Nu-Med Plus

Market Cap: US$4.2m

A medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide.

NUMD

US$0.05

7D

0%

1Y

3.6%

Optimus Healthcare Services

Market Cap: US$4.2m

Provides community-based oncology practices with the necessary infrastructure and support to enroll their patients on clinical trials in the United States.

OHCS

US$0.08

7D

0%

1Y

0%

Sweet Earth Holdings

Market Cap: CA$5.8m

Does not have significant operations.

SE

CA$0.45

7D

-16.7%

1Y

28.6%

ARCpoint

Market Cap: CA$5.8m

Provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States.

ARC

CA$0.045

7D

-40.0%

1Y

-52.6%

Aclarion

Market Cap: US$4.0m

Operates as a healthcare technology company in the United States.

ACON

US$6.94

7D

-2.3%

1Y

-99.8%

CompuMed

Market Cap: US$4.0m

An enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities.

CMPD

US$3.80

7D

15.2%

1Y

123.5%

Trellus Health

Market Cap: UK£3.0m

Provides digital chronic condition management solutions for employers and health plans.

TRLS

UK£0.018

7D

0%

1Y

12.1%

ATI Physical Therapy

Market Cap: US$4.0m

Operates as an outpatient physical therapy provider that provides outpatient rehabilitation and adjacent healthcare services through its clinics in the United States.

ATIP

US$0.90

7D

5.3%

1Y

-82.0%

Matinas BioPharma Holdings

Market Cap: US$3.9m

A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.

MTNB

US$0.87

7D

23.8%

1Y

-89.7%

Mosaic ImmunoEngineering

Market Cap: US$3.9m

A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.

CPMV

US$0.54

7D

-5.9%

1Y

35.0%

Mitesco

Market Cap: US$3.9m

Provides cloud computing, application hosting, and other data center related applications.

MITI

US$0.39

7D

-3.0%

1Y

37.9%

ProtoKinetix

Market Cap: US$3.9m

A research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).

PKTX

US$0.0089

7D

-11.5%

1Y

-40.4%

Adherium

Market Cap: AU$6.1m

Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.

ADR

AU$0.008

7D

0%

1Y

-52.9%

Lixte Biotechnology Holdings

Market Cap: US$3.9m

A clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.

LIXT

US$1.38

7D

13.5%

1Y

-43.9%

Galecto

Market Cap: US$3.9m

A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.

GLTO

US$2.88

7D

4.9%

1Y

-81.5%

Page 43 of 65